Literature DB >> 22592847

Pancreatic adenocarcinoma.

Giles Bond-Smith1, Neal Banga, Toby M Hammond, Charles J Imber.   

Abstract

Entities:  

Mesh：

Year:  2012        PMID： 22592847     DOI： 10.1136/bmj.e2476

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  61 in total

1.  Diagnostic value of IMP3 in pancreatic cancer: a meta-analysis.

Authors:  Qianqian Wang; Tao Wang; Zhu Wang; Hong Zheng
Journal:  Int J Clin Exp Med       Date:  2015-07-15

2.  Chronic stress accelerates pancreatic cancer growth and invasion: a critical role for beta-adrenergic signaling in the pancreatic microenvironment.

Authors:  Corina Kim-Fuchs; Caroline P Le; Matthew A Pimentel; David Shackleford; Davide Ferrari; Eliane Angst; Frédéric Hollande; Erica K Sloan
Journal:  Brain Behav Immun       Date:  2014-03-17       Impact factor: 7.217

3.  Diagnostic value of mesothelinin pancreatic cancer: a meta-analysis.

Authors:  Lin Zhu; Yiling Liu; Guangyuan Chen
Journal:  Int J Clin Exp Med       Date:  2014-11-15

4.  The long non-coding RNA HOTAIR affects the radiosensitivity of pancreatic ductal adenocarcinoma by regulating the expression of Wnt inhibitory factor 1.

Authors:  Yanhui Jiang; Zhihua Li; Shangyou Zheng; Huimou Chen; Xiaohui Zhao; Wenchao Gao; Zhuofei Bi; Kaiyun You; Yingxue Wang; Wenzhu Li; Liting Li; Yimin Liu; Rufu Chen
Journal:  Tumour Biol       Date:  2015-10-19

5.  Inhibition of pancreatic cancer cell migration by plasma anthocyanins isolated from healthy volunteers receiving an anthocyanin-rich berry juice.

Authors:  Sabine Kuntz; Clemens Kunz; Silvia Rudloff
Journal:  Eur J Nutr       Date:  2015-10-17       Impact factor: 5.614

6.  Curcumin induces apoptotic cell death in human pancreatic cancer cells via the miR-340/XIAP signaling pathway.

Authors:  Deying Yang; Yutao Li; Deqin Zhao
Journal:  Oncol Lett       Date:  2017-06-06       Impact factor: 2.967

7.  Novel therapeutic approaches for pancreatic cancer by combined targeting of RAF→MEK→ERK signaling and autophagy survival response.

Authors:  Faustino Mollinedo; Consuelo Gajate
Journal:  Ann Transl Med       Date:  2019-07

8.  Dual Inhibition of Hedgehog and c-Met Pathways for Pancreatic Cancer Treatment.

Authors:  Agnieszka A Rucki; Qian Xiao; Stephen Muth; Jianlin Chen; Xu Che; Jennifer Kleponis; Rajni Sharma; Robert A Anders; Elizabeth M Jaffee; Lei Zheng
Journal:  Mol Cancer Ther       Date:  2017-09-01       Impact factor: 6.261

9.  FOLFIRINOX treatment leading to pathologic complete response of a locally advanced pancreatic cancer.

Authors:  Andreas Minh Luu; Torsten Herzog; Philipp Hoehn; Anke Reinacher-Schick; Johanna Munding; Waldemar Uhl; Chris Braumann
Journal:  J Gastrointest Oncol       Date:  2018-04

10.  Expression and prognostic value of c-Myc and Fas (CD95/APO1) in patients with pancreatic cancer.

Authors:  Chengzhi He; Hua Jiang; Shasha Geng; Haihui Sheng; Xiaoying Shen; Xiaoyan Zhang; Shizhang Zhu; Ximei Chen; Changqing Yang; Hengjun Gao
Journal:  Int J Clin Exp Pathol       Date:  2014-01-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.